Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel
Gandhi R, Landovitz R, Sax P, Smith D, Springer S, Günthard H, Thompson M, Bedimo R, Benson C, Buchbinder S, Crabtree-Ramirez B, del Rio C, Eaton E, Eron J, Hoy J, Lehmann C, Molina J, Jacobsen D, Saag M. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. JAMA 2025, 333: 609-628. PMID: 39616604, DOI: 10.1001/jama.2024.24543.Peer-Reviewed Original ResearchAntiretroviral drugsHIV preventionSubstance use disordersLong-acting injectable therapyManagement of HIV infectionIntegrase strand transfer inhibitorsNucleotide reverse transcriptase inhibitorsStrand transfer inhibitorsSexually transmitted infectionsPeer-reviewed scientific conferencesDaily oral medicationReverse transcriptase inhibitorsLong-acting medicationsManagement of substance use disordersPrevention of HIVCardiovascular disease preventionTreating substance use disordersVirological failureAntiretroviral therapyHIV acquisitionHIV infectionHIV exposureInjection therapyDaily therapyLaboratory monitoring
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply